Synvista Therapeutics Appoints William Federici to its Board of...( MONTVALE N.J. Oct. 10 /- Synvista...),Health
Navigation Links
Synvista Therapeutics Appoints William Federici to its Board of Directors
Date:10/10/2008
MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announces that it has appointed William (Bill) Federici, 49, to its Board of Directors, expanding the board to five members.
Mr. Federici joined West Pharmaceutical Services as Vice President and Chief Financial Officer in August of 2003. Under his financial leadership, West Pharmaceutical's revenues have grown to more than $1.0 billion from $300 million. He has more than 20 years of public accounting experience, and was previously National Industry Director for Pharmaceuticals of KPMG LLP from June 2002 until August 2003. Prior to working at KPMG, he was an audit partner with Arthur Andersen, LLP where he began his career. During his tenure at Arthur Andersen, Mr. Federici worked with several major pharmaceutical companies and eventually became Global Pharmaceutical Industry Head from 1998 to 2002.
Noah Berkowitz, M.D., President and Chief Executive Officer of Synvista said, "We are fortunate that Bill has agreed to join our board, and we intend to tap into his significant knowledge base with respect to both his financial and pharmaceutical experience. We believe his background is a perfect fit for Synvista as we grow from a development stage company to one on the verge of launching a diagnostic product into the $79 billion diabetes market."
Mr. Federici is a past president and current Board member of CancerCare of New Jersey. He received a BA degree from Livingston College at Rutgers and an MBA from the Graduate School of Management at Rutgers.
About Synvista Therapeutics
Synvista Therapeutics is a biopharmaceutical company developing
diagnostics and drugs to diagnose, treat and prevent cardiovascular disease
in pe
'/>"/>
| SOURCE Synvista Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference
2. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
4. Cell Therapeutics Regains Compliance with NASDAQs Minimum Bid Price Requirement
5. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
6. Ikaria(R) Acquires North American Rights to LUCASSIN(R) From Orphan Therapeutics
7. Afid Therapeutics Inc.s New Anticoagulant Heparin Replacement Passes in Vivo Test
8. Industry Experts and Global Regulators to Discuss Oligonucleotide-Based Therapeutics Issues
9. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
10. TorreyPines Therapeutics Announces Management Change and Second Quarter 2008 Financial Results
11. Clinical Research Management gets contract for trials of therapeutics against infectious diseases
Post Your Comments:
(Date:11/28/2009)..., CHICAGO, Nov. 28 Welcome to ...ution for the clinical routine from Siemens Heal...munications System (PACS) from Siemens where 2D,... syngo .plaza is poised to change the way multim...g this innovation at the 95th Scientific Assembl...
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall/ -..."), a supplier of precision technology products an...nnual meeting of the Company,s shareholders has be... and location of the meeting will be announced in ...received a requisition notice from Stephen Bershad...
(Date:11/27/2009)... ROCHESTER, N.Y., Nov. 27 /PRNewswire-USNewswire/ ...care provider and fortunately every year, new vacc...on. But do all vaccines boost immunity for the sam... ,booster shots, needed to keep immunity strong? ...urnal of the American Academy of Pediatrics, Micha...
(Date:11/27/2009)...es to bring unprecedented medical, economic burden...ealthDay News) -- The number of people with diabet... the next 25 years, a new study predicts. , Tha...ion people with the disease, up from 23.7 million ...g people with diabetes will triple, the study also...
(Date:11/27/2009)... Three new interactive anatomy educa...mp; Wilkins expand health sciences learning opport... Durham, NC (Vocus) November 27, 2009 --...lkins (LWW), a division of Wolters Kluwer Health, ...omy education apps on the App Store. Clemente&rsqu...
Breaking Medicine News(10 mins):Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5[0] Siemens Healthcare Unveils syngo.plaza at RSNA 2009[0] GSI Group Calls Shareholders Meeting[0] Why Some Vaccines May Require A Booster[0] Diabetes Cases Expected to Double in 25 Years[0] Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store
...cialists at the Johns Hopkins Children’s Center an...ity children with chronic asthma //gets enough med...e.
The findings, reported in December's Pedia...tack strikes and to more complications and increas...
...l association announced on the 9th of November, ur...n the preparation of infant formulation. //
T...uoride at such a tender age might be disastrous as...ncer boys.
This advice is not noticed by many...
...m NHS Institute for Innovation and Improvement sug...ome by GPs and visiting //nurses rather than admit...report listed a range of conditions regularly seen...in hospital wards.
Home treatments will be...
...scovered that mutations in a gene known as SOS1 ac...mmon childhood genetic //disorder which occurs in ...d by short stature, facial abnormalities, and lear...ter for Genetics and Genomics (HPCGG) and Beth Isr...
...us consolation, nineteen persons infected with AID...ng this Chinas most moneyed lawsuit//. This money ...ir families as most of them are living in poverty....ree of them passed the virus to their spouses whil...
.../AIDS control programme has been working effective...A and some European countries//. UNAIDS has not in...med Forces for best practices for HIV prevention a...s initiated against any individual found HIV posit...
Other Medicine News:Health News:City Kids With Asthma Lose Out on Preventive Treatment 2Health News:Study Uncovers Mutation Responsible for Noonan Syndrome 2(Date:11/25/2009)..., CANOGA PARK, Calif., Nov. 25 ...lace rankings in the American Academy of Family Ph...2009 EHR User Satisfaction Survey for improving me...agement, all critical for new ARRA Stimulus legisl...ing their EMR had a positive effect in determining...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-FirstCal...r. Michael J. McKelvey, the Company,s President an...Vice President and CFO, are scheduled to present a...ence at 1:30 PM EST on December 1, 2009 in New Yor...ess the presentation by visiting the Company,s cor...
(Date:11/25/2009)..., COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNews...eloping a shaving cream-like foam that stops sever...t Promising Security Idea category of the Global S... today. ,, Selected from more than 100 entries ...ir invention at the GSC Security Summit conference...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 1Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 2Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 3Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 4Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 5Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 6Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 7Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 8Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 9Robbins 26amp 3B Myers Announces Fourth Quarter and Full Year 2009 Results 5236 10New Test Assesses Individual Breast Cancer Risk 58896 1New Test Assesses Individual Breast Cancer Risk 58896 2New Test Assesses Individual Breast Cancer Risk 58896 3SAGE launches Genes 26amp 3B Cancer 58891 1SAGE launches Genes 26amp 3B Cancer 58891 2...o Show Benefits of Hormone Thera... Sept. 25 Upsher-Smith Laboratories,Inc. today an...R),(estradiol gel) 0.1% were presented at the Nort... in Orlando, Florida. Divigel(R) is a,transdermal ...une 2007. It,offers the lowest approved dose of es...
...can Menopause Society 19th Annual ... 25 Bionovo, Inc.,(Nasdaq: BNVI ) will present a...didate, VG101, for the treatment of vaginal drynes...n Menopause Society in Orlando, Florida on,Septemb...hief medical,officer of Bionovo, will provide semi...
Other Medicine Technology:New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 2New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 3New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes 4Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 2Bionovo's VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |